Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00642
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2019
Authors
Publisher
Frontiers Media SA